XML 37 R25.htm IDEA: XBRL DOCUMENT v3.25.1
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2025
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Alan Pickerill [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Alan Pickerill, our Lead Independent Director, entered into a Rule 10b5-1 trading arrangement on March 13, 2025 (as such term is defined in Item 408(a) of Regulation S-K) (the “10b5-1 Plan”). The 10b5-1 Plan is scheduled to terminate on March 17, 2026, and covers the sale of up to an aggregate of 40,000 shares of the Company’s common stock to help satisfy tax obligations upon the vesting of shares received for service on the Board of Directors. The 10b5-1 Plan is intended to satisfy the affirmative defense Rule of 10b5-1(c). Trades under the 10b5-1 Plan will not commence until at least 90 days following the date on which such plan was entered.
Name Alan Pickerill
Title Lead Independent Director
Rule 10b5-1 Arrangement Adopted true
Adoption Date March 13, 2025
Expiration Date March 17, 2026
Arrangement Duration 369 days
Aggregate Available 40,000
Rachel Lam [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Rachel Lam, a member of our Board of Directors, entered into a 10b5-1 Plan on March 14, 2025. The 10b5-1 Plan is scheduled to terminate on March 16, 2026, and covers the sale of up to an aggregate of 50,000 shares of the Company’s common stock to help satisfy tax obligations upon the vesting of shares received for service on the Board of Directors. The 10b5-1 Plan is intended to satisfy the affirmative defense Rule of 10b5-1(c). Trades under the 10b5-1 Plan will not commence until at least 90 days following the date on which such plan was entered.
Name Rachel Lam
Title a member of our Board of Directors
Rule 10b5-1 Arrangement Adopted true
Adoption Date March 14, 2025
Expiration Date March 16, 2026
Arrangement Duration 367 days
Aggregate Available 50,000